Fig. 5: Simulated Molecular Interactions of USP6 with Selected Inhibitors, and closeup views of the compound binding site highlighting key residues.
From: Physiological roles and therapeutic implications of USP6
A USP6–CYT387, (B) USP6-FT385, (C) USP6-PR619, (D) USP6-USP30 In-1, (E) USP6-USP30 In-2, (F) USP6-USP30 In-3.
